Dhorda M, Piola P, Nyehangane D, Tumwebaze B, Nalusaji A, et al.
2012-01-01 • PLOS One
2012-01-01 • PLOS One
Abstract. Improved laboratory diagnosis is critical to reduce the burden of malaria in pregnancy. Peripheral blood smears appear less sensitive than Plasmodium falciparum histidine-rich ...
Muehlenbachs A, Nabasumba C, McGready R, Turyakira E, Tumwebaze B, et al.
2012-05-03 • Malaria Journal
2012-05-03 • Malaria Journal
BACKGROUND Data on efficacy of artemisinin-based combination therapy (ACT) to treat Plasmodium falciparum during pregnancy in sub-Saharan Africa is scarce. A recent open label, rando...
Kloprogge F, Workman L, Borrmann S, Tekete M, Lefevre G, et al.
2018-06-12 • PLOS Medicine
2018-06-12 • PLOS Medicine
The fixed dose combination of artemether-lumefantrine (AL) is the most widely used treatment for uncomplicated Plasmodium falciparum malaria. Relatively lower cure rates and lumefantrine...
De Beaudrap P, Turyakira E, White LJ, Nabasumba C, Tumwebaze B, et al.
2013-04-24 • Malaria Journal
2013-04-24 • Malaria Journal
BACKGROUND Malaria in pregnancy (MiP) is a major public health problem in endemic areas of sub-Saharan Africa and has important consequences on birth outcome. Because MiP is a comple...
Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, et al.
2010-11-01 • Lancet Infectious Diseases
2010-11-01 • Lancet Infectious Diseases
BACKGROUND: Malaria in pregnancy is associated with maternal and fetal morbidity and mortality. In 2006, WHO recommended use of artemisinin-based combination treatments during the second...
Tarning J, Ashley EA, Lindegardh N, Stepniewska K, Phaiphun L, et al.
2008-03-01 • Antimicrobial Agents and Chemotherapy
2008-03-01 • Antimicrobial Agents and Chemotherapy
The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria treated with two different dosage regimens of dihydroartemisinin-pi...
De Beaudrap P, Turyakira E, Nabasumba C, Tumwebaze B, Piola P, et al.
2016-02-16 • Malaria Journal
2016-02-16 • Malaria Journal
BACKGROUND Malaria in pregnancy (MiP) is a major cause of fetal growth restriction and low birth weight in endemic areas of sub-Saharan Africa. Understanding of the impact of MiP on ...
Hossain MS, Commons RJ, Douglas NM, Thriemer KL, Alemayehu BH, et al.
2020-11-19 • PLOS Medicine
2020-11-19 • PLOS Medicine
Background: There is a high risk of Plasmodium vivax parasitaemia following treatment of falciparum malaria. Our study aimed to quantify this risk and the associated determinants using a...
